{"date":"2026-05-22","count":67,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4743-2026-05-22-2102-h4so80","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"21:02:42","subject":"本公司ON101乳膏於治療糖尿病足潰瘍（DFU）癒合療效與降低截肢率之系統性回顧與網絡統合分析成果，發表於國際權威SCI期刊《BMJ Open Diabetes Research & Care》","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-05-22 21:02，「本公司ON101乳膏於治療糖尿病足潰瘍（DFU）癒合療效與降低截肢率之系統性回顧與網絡統合分析成果，發表於國際權威SCI」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-05-22-1809-1jb8ii5","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"18:09:22","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-05-22 18:09，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-05-22-1752-1aq7iqo","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:52:49","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-06-04","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-05-22 17:52，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1744-wm72ws","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:44:31","subject":"公告本公司永續發展委員會委員任期屆滿","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:44，「公告本公司永續發展委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1744-1w8o0p8","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:44:12","subject":"公告本公司提名委員會委員任期屆滿","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:44，「公告本公司提名委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1743-1bllz6i","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:43:56","subject":"公告本公司風險管理委員會委員任期屆滿","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:43，「公告本公司風險管理委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1743-cobe39","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:43:40","subject":"公告本公司115年股東常會重要決議","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:43，「公告本公司115年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1743-s0kpz3","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:43:26","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:43，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1743-9769qc","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:43:24","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:43，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1743-13sk2v0","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:43:10","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:43，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1742-1g41lqr","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:42:54","subject":"公告本公司薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:42，「公告本公司薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1742-1irfdyf","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:42:34","subject":"公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:42，「公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-22-1742-17k262x","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:42:18","subject":"公告本公司115年股東常會全面改選董事及獨立董事當選名單，暨董事變動達三分之1以上","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-22 17:42，「公告本公司115年股東常會全面改選董事及獨立董事當選名單，暨董事變動達三分之1以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-05-22-1741-18forp2","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:41:17","subject":"更正一一五年第一季合併財務報告附註內容","clause":"第53款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-05-22 17:41，「更正一一五年第一季合併財務報告附註內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-05-22-1735-1k1fn72","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:35:27","subject":"公告本公司第二屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-05-22 17:35，「公告本公司第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-05-22-1734-7j7htv","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:34:11","subject":"公告本公司第一屆審計委員會委員","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-05-22 17:34，「公告本公司第一屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-22-1733-p67uuk","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:33:31","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-22 17:33，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-05-22-1733-sbdmgb","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:33:01","subject":"本公司董事會推選蔣永芳博士續任董事長","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-05-22 17:33，「本公司董事會推選蔣永芳博士續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-05-22-1731-sqgrt0","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:31:48","subject":"公告本公司法人董事代表人異動","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-05-22 17:31，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-05-22-1730-1dcj8my","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:30:53","subject":"代子公司江蘇視准醫療器械有限公司公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-05-22 17:30，「代子公司江蘇視准醫療器械有限公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-05-22-1730-m9k8dq","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:30:25","subject":"公告本公司115年股東常會決議解除董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-05-22 17:30，「公告本公司115年股東常會決議解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-05-22-1728-1pgsthn","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:28:30","subject":"公告本公司115年股東常會改選董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-05-22 17:28，「公告本公司115年股東常會改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-05-22-1726-1jb8ii5","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:26:43","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-05-22 17:26，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1721-bkpr3i","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:21:07","subject":"公告本公司設置風險管理委員會暨委任風險管理委員會委員","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:21，「公告本公司設置風險管理委員會暨委任風險管理委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1720-11fwjai","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:20:44","subject":"公告本公司永續發展委員會任期屆滿選任","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:20，「公告本公司永續發展委員會任期屆滿選任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-22-1720-1qv4g4g","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:20:17","subject":"公告本公司第三屆審計委員會名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-22 17:20，「公告本公司第三屆審計委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1720-5cz18d","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:20:15","subject":"公告本公司薪資報酬委員會任期屆滿委任","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:20，「公告本公司薪資報酬委員會任期屆滿委任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-22-1719-1xp4un9","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:19:37","subject":"公告本公司第三屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-22 17:19，「公告本公司第三屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-22-1719-9769qc","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:19:06","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-22 17:19，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-22-1718-w4l0am","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:18:32","subject":"公告本公司股東常會決議通過解除董事競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-22 17:18，「公告本公司股東常會決議通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-22-1716-3nak6n","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:16:33","subject":"公告本公司115年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-22 17:16，「公告本公司115年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-05-22-1715-9769qc","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:15:42","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-05-22 17:15，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-22-1714-1jb8ii5","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:14:59","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-22 17:14，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1714-miq4h0","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:14:50","subject":"公告本公司一百一十五年五月二十二日股東常會改選董事相關事宜(更正新任者選任時持股數)","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 17:14，「公告本公司一百一十五年五月二十二日股東常會改選董事相關事宜(更正新任者選任時持股數)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1714-hmekex","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"17:14:23","subject":"公告本公司一百一十五年股東常會重要決議事項(更正決議事項一)","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 17:14，「公告本公司一百一十五年股東常會重要決議事項(更正決議事項一)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1708-gnsik8","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:08:12","subject":"公告本公司審計委員會任期屆滿委任","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:08，「公告本公司審計委員會任期屆滿委任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1706-s93snt","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:06:47","subject":"公告本公司115年股東常會決議解除新任董事從事競業禁止情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:06，「公告本公司115年股東常會決議解除新任董事從事競業禁止情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-05-22-1706-1uhskx3","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"17:06:44","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-05-22 17:06，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1706-15xifh4","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:06:18","subject":"公告本公司115年股東常會全面改選董事九席名單(含獨立董事三席)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:06，「公告本公司115年股東常會全面改選董事九席名單(含獨立董事三席)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-22-1704-1jb8ii5","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:04:35","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-22 17:04，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-05-22-1704-rwkk3n","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"17:04:13","subject":"本公司受桃園市政府、新北市政府及勞動部累計裁處罰鍰新台幣100萬元以上","clause":"第26款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-05-22 17:04，「本公司受桃園市政府、新北市政府及勞動部累計裁處罰鍰新台幣100萬元以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-05-22-1654-1an4t11","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"16:54:00","subject":"本公司電子式關節鏡EJA100通過台灣衛福部食藥署(TFDA)第二類醫療器材審查","clause":"第51款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-05-22 16:54，「本公司電子式關節鏡EJA100通過台灣衛福部食藥署(TFDA)第二類醫療器材審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-05-22-1646-1ye9hvp","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"16:46:43","subject":"公告本公司董事會決議委託關係人執行GMP細胞工廠之技術諮詢與整合性統包服務","clause":"第44款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-05-22 16:46，「公告本公司董事會決議委託關係人執行GMP細胞工廠之技術諮詢與整合性統包服務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-05-22-1646-sp7sb3","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"16:46:08","subject":"（修正1150507重大訊息）公告本公司董事會決議辦理私募現金增資發行普通股案","clause":"第9款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-05-22 16:46，「（修正1150507重大訊息）公告本公司董事會決議辦理私募現金增資發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-05-22-1631-10jca0t","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"16:31:58","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-05-22 16:31，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-05-22-1622-js2vlt","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"16:22:32","subject":"公告本公司第一屆薪酬委員任期屆滿","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-05-22 16:22，「公告本公司第一屆薪酬委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-05-22-1621-r8x24z","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"16:21:26","subject":"公告本公司審計委員會委員任期屆滿改選","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-05-22 16:21，「公告本公司審計委員會委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-05-22-1620-30bydm","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"16:20:39","subject":"公告本公司2026年股東常會通過解除新任董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-05-22 16:20，「公告本公司2026年股東常會通過解除新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-05-22-1619-14tfvmm","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"16:19:42","subject":"公告本公司2026年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-05-22 16:19，「公告本公司2026年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-05-22-1618-4yzujo","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"16:18:37","subject":"公告本公司訂定除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-05-22 16:18，「公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-05-22-1617-lewzru","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"16:17:16","subject":"公告本公司2026年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-05-22 16:17，「公告本公司2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-05-22-1550-1jb8ii5","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"15:50:12","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-05-22 15:50，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-05-22-1539-1lw8gsn","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"15:39:23","subject":"公告本公司限制員工權利新股註銷完成變更登記事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-05-22 15:39，「公告本公司限制員工權利新股註銷完成變更登記事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-05-22-1508-1g6i233","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"15:08:34","subject":"公告本公司董事長異動","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-05-22 15:08，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-05-22-1451-qcx1gh","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"14:51:32","subject":"公告本公司決議除息基準日","clause":"第14款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-05-22 14:51，「公告本公司決議除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-05-22-1449-1jb8ii5","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"14:49:39","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-05-22 14:49，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-22-1428-131v47z","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"14:28:44","subject":"公告本公司114年第二次私募普通股收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-22 14:28，「公告本公司114年第二次私募普通股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1333-pb0x6f","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"13:33:56","subject":"公告本公司一百一十五年五月二十二日股東常會改選董事相關事宜","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 13:33，「公告本公司一百一十五年五月二十二日股東常會改選董事相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1333-t6jioo","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"13:33:02","subject":"公告本公司董事會決議委任第三屆審計委員會委員及召集人","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 13:33，「公告本公司董事會決議委任第三屆審計委員會委員及召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1332-16luvi1","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"13:32:45","subject":"公告本公司董事會決議委任第七屆薪酬委員會委員","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 13:32，「公告本公司董事會決議委任第七屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1332-uuoh2o","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"13:32:26","subject":"公告本公司115年股東常會通過解除董事及其代表人競業禁止之限制","clause":"第21款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 13:32，「公告本公司115年股東常會通過解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1331-kk44ir","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"13:31:52","subject":"公告本公司一百一十五年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 13:31，「公告本公司一百一十五年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-05-22-1331-14iohyp","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"13:31:35","subject":"公告本公司選任董事長案","clause":"第6款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-05-22 13:31，「公告本公司選任董事長案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-05-22-1221-zk0qd9","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-05-22","time":"12:21:45","subject":"公告本公司115年股東常會重要決議事項。","clause":"第18款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-05-22 12:21，「公告本公司115年股東常會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-05-22-1209-lewzru","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-05-22","time":"12:09:03","subject":"公告本公司2026年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-05-22 12:09，「公告本公司2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-05-22-0800-k428b9","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"08:00:13","subject":"中裕新藥TMB-365/380臨床2b完成最後受試者收治（LPI），正式邁入數據讀取與全球授權關鍵階段","clause":"第53款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-05-22 08:00，「中裕新藥TMB-365/380臨床2b完成最後受試者收治（LPI），正式邁入數據讀取與全球授權關鍵階段」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-05-22-0638-11vjyqz","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-05-22","time":"06:38:55","subject":"開發中新藥OBP-301日本藥事審議會結論公告","clause":"第53款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-05-22 06:38，「開發中新藥OBP-301日本藥事審議會結論公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}